These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11813862)

  • 1. The Ca2+-binding S100A2 protein is differentially expressed in epithelial tissue of glandular or squamous origin.
    Nagy N; Hoyaux D; Gielen I; Schäfer BW; Pochet R; Heizmann CW; Kiss R; Salmon I; Decaestecker C
    Histol Histopathol; 2002 Jan; 17(1):123-30. PubMed ID: 11813862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.
    Feng G; Xu X; Youssef EM; Lotan R
    Cancer Res; 2001 Nov; 61(21):7999-8004. PubMed ID: 11691825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration.
    Nagy N; Brenner C; Markadieu N; Chaboteaux C; Camby I; Schäfer BW; Pochet R; Heizmann CW; Salmon I; Kiss R; Decaestecker C
    Lab Invest; 2001 Apr; 81(4):599-612. PubMed ID: 11304580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of S100A2 in lymph node metastases of head and neck cancer.
    Zhang X; Hunt JL; Shin DM; Chen ZG
    Head Neck; 2007 Mar; 29(3):236-43. PubMed ID: 17123307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the Ca(2+) binding protein S100A2 in laryngeal squamous-cell carcinoma.
    Lauriola L; Michetti F; Maggiano N; Galli J; Cadoni G; Schäfer BW; Heizmann CW; Ranelletti FO
    Int J Cancer; 2000 Jul; 89(4):345-9. PubMed ID: 10956408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic significance of S100A2 protein in squamous cell carcinoma of the esophagus.
    Kyriazanos ID; Tachibana M; Dhar DK; Shibakita M; Ono T; Kohno H; Nagasue N
    Oncol Rep; 2002; 9(3):503-10. PubMed ID: 11956617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A2 expression as a predictive marker for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral cavity.
    Suzuki F; Oridate N; Homma A; Nakamaru Y; Nagahashi T; Yagi K; Yamaguchi S; Furuta Y; Fukuda S
    Oncol Rep; 2005 Dec; 14(6):1493-8. PubMed ID: 16273244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas.
    Smith SL; Gugger M; Hoban P; Ratschiller D; Watson SG; Field JK; Betticher DC; Heighway J
    Br J Cancer; 2004 Oct; 91(8):1515-24. PubMed ID: 15467767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
    Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
    Rehman I; Cross SS; Catto JW; Leiblich A; Mukherjee A; Azzouzi AR; Leung HY; Hamdy FC
    Prostate; 2005 Dec; 65(4):322-30. PubMed ID: 16015609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of calcium-binding protein S100A2 in breast lesions.
    Liu D; Rudland PS; Sibson DR; Platt-Higgins A; Barraclough R
    Br J Cancer; 2000 Dec; 83(11):1473-9. PubMed ID: 11076656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of S100A2 and S100B proteins in epithelial tumors of the skin.
    Park HR; Min SK
    J Cutan Pathol; 2003 Jul; 30(6):373-8. PubMed ID: 12834486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished expression of S100A2, a putative tumour suppressor, is an independent predictive factor of neck node relapse in laryngeal squamous cell carcinoma.
    Almadori G; Bussu F; Galli J; Rigante M; Lauriola L; Michetti F; Maggiano N; Schafer BW; Heizmann CW; Ranelletti FO; Paludetti G
    J Otolaryngol Head Neck Surg; 2009 Feb; 38(1):16-22. PubMed ID: 19344608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of S100A2 and S100A6 in thyroid carcinomas.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
    Histopathology; 2005 May; 46(5):569-75. PubMed ID: 15842639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iTRAQ-based quantitative proteomic analysis on S100 calcium binding protein A2 in metastasis of laryngeal cancer.
    Zha C; Jiang XH; Peng SF
    PLoS One; 2015; 10(4):e0122322. PubMed ID: 25874882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of S100A2 in secondarily radioresistant pancreatic cancer cells and significance thereof].
    Wen Q; Zhao YP; Chen G; Zhang FQ; Zhang TP
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2817-20. PubMed ID: 17200013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer.
    Strazisar M; Rott T; Glavac D
    Lung Cancer; 2009 Mar; 63(3):354-9. PubMed ID: 18656279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis.
    Villaret DB; Wang T; Dillon D; Xu J; Sivam D; Cheever MA; Reed SG
    Laryngoscope; 2000 Mar; 110(3 Pt 1):374-81. PubMed ID: 10718422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients.
    Kumar M; Srivastava G; Kaur J; Assi J; Alyass A; Leong I; MacMillan C; Witterick I; Shukla NK; Thakar A; Duggal R; Roychoudhury A; Sharma MC; Walfish PG; Chauhan SS; Ralhan R
    J Transl Med; 2015 Jan; 13():8. PubMed ID: 25591983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression Profile of S100A2 and its Clinicopathological Significance in Renal Cell Carcinoma.
    Sugiyama T; Ozono S; Miyake H
    Anticancer Res; 2020 Nov; 40(11):6337-6343. PubMed ID: 33109571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.